Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

STOPHCVlogowithstrapline.gif

stophcvmrc.jpg

In this Section

About STOP-HCV

STOP-HCV is a Medical Research Council (MRC) funded consortium which aims to use patient information to establish the most effective and cost effective treatments for patients with Hepatitis C Virus.

Professor Ellie Barnes (STOP-HCV lead) talks to the Oxford Centre for Personalised Medicine about the project.

Read More

STOP-HCV Partners

The STOP-HCV consortium is formed of 17 partners representing academia, industry and the Hepatitis C Trust.

Find out more

Publications

Read more about the science we've published.

Read More

Podcasts

Find out more about STOP-HCV from members of the STOP-HCV Consortium.

Watch the podcasts

Latest News

Lancet Commission on hepatitis elimination, led by Professor Graham Cooke, now available online.

Public Health England’s (PHE) Hepatitis C Virus Resistance Group publishes guidance on antiviral resistance testing in the management of hepatitis C. 

"Battling a silent killer" Read this interview with  Professor Ellie Barnes and Dr Emma Hudson for  Impact open access science reports . 

"Diagnosis and research key to hepatitis elimination".  Read this post by Professor John McLauchlan, written for the MRC Insight.

Extending STOP-HCV to S.E. Asia through recent awards from the MRC and the Wellcome Trust. Two recent awards  will enable the consortium to extend its activities to Vietnam in S.E Asia

STOP-HCV genetic study - published in Nature Genetics (10 April 2017). Oxford University news describe the study which shows, for the first time, how the genetic make-up of HCV is influenced by its host.

STOP-HCV Cirrhosis Study reaches 1200 patient recruitment target. 1264 patients (recruited from over 30 hospital sites) are enrolled in the STOP-HCV Cirrhosis Study. 

STOP-HCV Consortium publishes findings from its HCV next generation sequencing methods comparison exercise - available online at Journal of Clinical Microbiology.